About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Ethics Approval to Commence Topical TPM®/Oxycodone Patch Trial
December 8, 2014
Click here to read more
Post navigation
Previous Post
Phosphagenics Newsletter November 2014
Next Post
Phosphagenics Appoints Dr Ross Murdoch as Chief Executive Officer
Related Posts
Phosphagenics Provides Update on TPM Propofol Development Program
November 9, 2017
2017 AGM Resuls
May 31, 2017
2016 July 29 CEO Quarterly Update
July 29, 2016